Russell Frank Company’s Allergan plc AGN Stock Holding History

Russell Frank Company’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$203M	Buy	755,595 +28,049	+4%	+$8.03M	0.36%	43
2015 Q4	$229M	Sell	727,546 -201,560	-22%	-$60M	0.4%	40
2015 Q3	$252M	Sell	929,106 -43,250	-4%	-$13.3M	0.47%	28
2015 Q2	$295M	Buy	972,356 +89,471	+10%	+$26.7M	0.47%	25
2015 Q1	$263M	Buy	882,885 +181,589	+26%	+$51.8M	0.48%	23
2014 Q4	$182M	Buy	701,296 +29,293	+4%	+$7.32M	0.32%	62
2014 Q3	$162M	Buy	672,003 +236,444	+54%	+$52.9M	0.29%	72
2014 Q2	$97.1M	Buy	435,559 +5,723	+1%	+$1.18M	0.17%	141
2014 Q1	$88.5M	Sell	429,836 -92,319	-18%	-$18.3M	0.16%	163
2013 Q4	$86.4M	Buy	522,155 +245,011	+88%	+$38.3M	0.16%	146
2013 Q3	$39.9M	Sell	277,144 -63,715	-19%	-$8.49M	0.07%	325
2013 Q2	$43M	Buy	+340,859	New	+$38.6M	0.08%	293

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Russell Frank Company's AGN Position: Q1 2016 in Review

Russell Frank Company increased its Allergan plc (AGN) stake by 3.9% in Q1 2016, buying an estimated $8.03M and bringing the position to 755,595 shares worth $203M. The position accounts for 0.36% of the portfolio, ranked #43.

Russell Frank Company first reported a position in AGN in Q2 2013 and has held it in 12 quarters since. The position peaked at $295M in Q2 2015. 1,119 funds tracked by Wall St. Rank hold AGN as of Q1 2016.

Russell Frank Company held 755,595 shares of Allergan plc worth $203M as of Q1 2016.
Russell Frank Company bought 28,049 Allergan plc shares in Q1 2016, an estimated $8.03M.
Allergan plc made up 0.36% of Russell Frank Company's portfolio in Q1 2016, its #43 holding.
Russell Frank Company first reported a position in Allergan plc in Q2 2013 and has held it in 12 quarters since.
Russell Frank Company's Allergan plc position peaked at $295M in Q2 2015.
1,119 funds tracked by Wall St. Rank held Allergan plc as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.